These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7863988)

  • 1. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
    Crouse JR; Byington RP; Bond MG; Espeland MA; Craven TE; Sprinkle JW; McGovern ME; Furberg CD
    Am J Cardiol; 1995 Mar; 75(7):455-9. PubMed ID: 7863988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
    Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG
    Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
    Crouse JR; Byington RP; Bond MG; Espeland MA; Sprinkle JW; McGovern M; Furberg CD
    Control Clin Trials; 1992 Dec; 13(6):495-506. PubMed ID: 1334821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
    Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
    MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H
    Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.
    Salonen R; Nyssönen K; Porkkala-Sarataho E; Salonen JT
    Am J Cardiol; 1995 Sep; 76(9):34C-39C. PubMed ID: 7572684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).
    de Groot E; Jukema JW; Montauban van Swijndregt AD; Zwinderman AH; Ackerstaff RG; van der Steen AF; Bom N; Lie KI; Bruschke AV
    J Am Coll Cardiol; 1998 Jun; 31(7):1561-7. PubMed ID: 9626835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.
    Probstfield JL; Margitic SE; Byington RP; Espeland MA; Furberg CD
    Am J Cardiol; 1995 Sep; 76(9):47C-53C. PubMed ID: 7572686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
    Furberg CD; Adams HP; Applegate WB; Byington RP; Espeland MA; Hartwell T; Hunninghake DB; Lefkowitz DS; Probstfield J; Riley WA
    Circulation; 1994 Oct; 90(4):1679-87. PubMed ID: 7734010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.
    Pitt B; Mancini GB; Ellis SG; Rosman HS; Park JS; McGovern ME
    J Am Coll Cardiol; 1995 Nov; 26(5):1133-9. PubMed ID: 7594023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography.
    Espeland MA; Hoen H; Byington R; Howard G; Riley WA; Furberg CD
    Stroke; 1994 Sep; 25(9):1812-9. PubMed ID: 8073462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries.
    Furberg CD; Pitt B; Byington RP; Park JS; McGovern ME
    Am J Cardiol; 1995 Sep; 76(9):60C-63C. PubMed ID: 7572689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients.
    Inukai T; Yamamoto R; Suetsugu M; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Takebayashi K; Aso Y
    J Diabetes Complications; 2005; 19(5):269-75. PubMed ID: 16112502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study.
    de Groot E; Jukema JW; van Boven AJ; Reiber JH; Zwinderman AH; Lie KI; Ackerstaff RA; Bruschke AV
    Am J Cardiol; 1995 Sep; 76(9):40C-46C. PubMed ID: 7572685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.
    Borhani NO; Mercuri M; Borhani PA; Buckalew VM; Canossa-Terris M; Carr AA; Kappagoda T; Rocco MV; Schnaper HW; Sowers JR; Bond MG
    JAMA; 1996 Sep; 276(10):785-91. PubMed ID: 8769587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness.
    Markus RA; Mack WJ; Azen SP; Hodis HN
    Am J Clin Nutr; 1997 Apr; 65(4):1000-4. PubMed ID: 9094885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
    JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
    Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
    Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
    Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.